
### [NCIT:C3640](http://purl.obolibrary.org/obo/NCIT_C3640)
**Label:** Stage 0 Skin Cancer

**Subclasses:** [NCIT:C62571](http://purl.obolibrary.org/obo/NCIT_C62571) (Bowen Disease of the Skin), [NCIT:C5893](http://purl.obolibrary.org/obo/NCIT_C5893) (Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7), [NCIT:C2906](http://purl.obolibrary.org/obo/NCIT_C2906) (Skin Squamous Cell Carcinoma In Situ), 

**Class expressions from DL-Learner:**

- Thing 53.40%
- [NCIT:C47805](http://purl.obolibrary.org/obo/NCIT_C47805) (Malignant Neuroendocrine Small Round Cell) 52.78%
- [NCIT:C28079](http://purl.obolibrary.org/obo/NCIT_C28079) (Grade 3) 52.78%
- [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 38.13%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 38.13%


